查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1247443

2023-2030 年全球药物管理市场

Global Medication Management Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

全球药物管理市场规模预计到 2022 年将达到 246934 万美元，到 2030 年将达到 1012943 万美元，预测期内（2023-2030 年）的复合年增长率为 20.00%。预计将在

药物管理是与患者和护理人员沟通的策略，以创建准确、全面的所有消耗药物清单。 完整准确的处方清单是解决药品核对管理问题的第一步。 这些工具可识别可能使患者面临药物相关不良事件风险的行为，例如用药过量或用药不足、忘记服药或其他影响依从性的重要背景因素。也有帮助。

市场动态

推动全球药房管理市场的主要因素是行业参与者推出产品推动市场发展，越来越多的医院投资于创新技术，随着全球处方数量的增加，该行业有望快速增长。

市场进入者推出的产品正在推动市场的发展。

对新产品发布的投资增加、医疗保健流程管理的改进以及处方错误的减少预计将推动市场扩张。

例如，2023 年 1 月，我们根据某些合同安排合併其财务业绩的中国实体之一中新医疗科技（有限公司）（“中新”）推出了“药物管理支持”微信小程序”（“小程序”）管理癌症患者的各种问题，为癌症和其他重大疾病患者提供服务。它由提供医疗用品的基于平台的互联网技术公司众巢公司宣布, Zhongxin 建立了帮助癌症患者导航和克服药物挑战的计划。

2020 年 11 月，位于马萨诸塞州波士顿的数字治疗配套平台 Medisafe 宣布立即实施其革命性的 Medisafe Maestro 平台。 这个最先进的系统可以精确、快速地安排患者的旅程，创建与数字药物伴侣一起提供的个性化患者护理资源。 Medisafe 通过集成的 Care Connector 为製药行业提供数字患者护理资源，实现实时患者参与和个性化数字药物伴侣。

低意识预计会阻碍市场增长。

然而，阻碍药物管理系统市场增长的其他因素包括欠发达国家对此类系统的认识不足以及与此类系统相关的高成本。

COVID-19 影响分析

COVID-19 大流行对经济产生了积极影响。 由于大流行，世界各地的医疗机构都承受着巨大的压力。 实施封锁和社会隔离以防止疾病传播。 慢性病患者正在遭受痛苦，因为他们无法使用医疗设施进行常规治疗和药物分发。 得益于零售药店，这些人可以快速轻鬆地获得帮助。 在 COVID-19 大流行期间提供药物时，社区药剂师致力于为访问其设施的客户预防、识别和解决药物问题。

区域药剂师非常适合这个职位，因为他们是 COVID-19 大流行期间最平易近人的医疗保健专业人员群体。 社区药师可以解决不合理用药的突出问题，促进普通大众和慢性病患者等特殊人群的合理用药。 在大流行期间，社区药剂师参与管理慢性健康状况并促进这些中心的药物依从性对于缓解世界上过度劳累的医疗保健系统的压力至关重要。

内容

第 1 章研究方法和范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 市场进入者推出产品有助于市场发展
      • 越来越多的医院在创新技术上投入更多资金
    • 阻止因素：
      • 认知度低预计会阻碍市场增长
    • 机会
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 价格分析
  • 监管分析

第 6 章 COVID-19 分析

  • 市场上 COVID-19 的分析
    • 在 COVID-19 市场情景之前
    • 当前的 COVID-19 市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格和动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 结论

第 7 章按软件类型分类

  • 计算机订单输入 (CPOE)
    • 临床决策支持系统 (CDSS)
    • 电子药品管理记录
    • 库存管理系统
    • 其他

第八章服务

  • 医学分析服务
  • ADE 监控服务
  • 护理点验证服务

第九章运输方式

  • 基于网络
  • 基于云
  • 本地

第 10 章最终用户

  • 医院
  • 药房
  • 其他

第11章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第12章竞争格局

  • 主要发展和战略
  • 公司股票分析
  • 产品基准
  • 知名大公司名单

第13章公司简介

  • 通用电气医疗
    • 公司简介
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • QUALCOMM Incorporated
  • Omnicell, Inc
  • Talyst, LLC
  • Allscripts Healthcare Solutions Inc.
  • ARxIUM
  • Becton Dickinson and Company
  • Cerner Corporation
  • QuadraMed Affinity Corporation
  • McKesson Corporation

第14章 DataM

简介目录
Product Code: HCIT1783

Market Overview

The global medication management market size was valued at US$ 2,469.34 million in 2022 and is estimated to reach US$ 10,129.43 million by 2030, growing at a CAGR of 20.00% during the forecast period (2023-2030).

Medication management is a strategy for communicating with patients and caregivers to create a precise and thorough inventory of all the medications consumed. A complete and accurate prescription list is the first step in solving medication reconciliation and management problems. These tools can also help identify behaviors that may put patients at risk for drug-related adverse events, such as overdosing or underdosing on medications, forgetting to take them, or other important contextual factors that impede adherence.

Market Dynamics

The major factors driving the global Medication management market the product launches by industry participants are aiding the market to develop, the growing number of hospitals putting more money into innovative technology and the industry is anticipated to grow quickly as the number of prescriptions worldwide increases.

Product launches by industry participants are aiding the market's growth.

Increased investments in the launch of new products, improved healthcare process management, and reduced prescription error is predicted to drive market expansion.

For instance, in January 2023, Zhongxin Medical Technology Co., Ltd. ("Zhongxin"), one of the China operating entities with which the Company consolidates the financial results through certain contractual arrangements, launched the Medication Management Assistance Mini Program on WeChat (the "Program") to help cancer patients manage a variety of issues. Zhongchao Inc., a platform-based internet technology company that provides services to patients with oncology and other serious diseases, made the announcement. To help cancer patients navigate and overcome pharmaceutical problems, Zhongxin established the Program.

And in November 2020, the Boston, Massachusetts-based digital therapeutics companion platform Medisafe has announced the immediate implementation of its innovative Medisafe Maestro platform. This state-of-the-art system orchestrates medication adherence journeys with precision and speed while creating personalized patient care resources that are provided via a digital drug companion. Medisafe provides the pharmaceutical industry with digital patient care resources through its integrated Care Connector, which results in real-time patient involvement and personalized digital drug companions.

Lack of awareness is expected to hamper the market's growth.

However, other factors impeding the growth of the medication management system market include limited awareness of such systems in underdeveloped nations and greater costs related to such systems.

COVID-19 Impact Analysis

The COVID-19 pandemic had a positive impact on the economy. Medical facilities all over the world are under a great deal of stress as a result of the pandemic. To avoid the illness from spreading, lockdowns and social isolation were implemented. Patients with chronic illnesses who could not access healthcare facilities for routine treatment and medication distribution suffered. Thanks to retail pharmacies, these people may get help quickly and easily. Community pharmacists will concentrate on preventing, identifying, and resolving drug therapy difficulties for clients coming to their facility when delivering pharmaceutical care during the COVID-19 pandemic.

Because they are the most approachable group of healthcare professionals during the COVID-19 pandemic, community pharmacists are well-suited for this position. They can address the serious problems of inappropriate medication use and promote rational medication use to members of the general public and special populations like patients with chronic illnesses. Community pharmacists' participation in these centers' management of chronic health conditions and promotion of medication adherence during the pandemic was crucial in easing the pressure on the world's overworked healthcare systems.

Segment Analysis

The medication analytic services segment is expected to grow at the fastest CAGR during the forecast period (2022-2030)

The service segment is the highest market holder in the global Medication management market. Data analytics is the practice of examining unprocessed datasets for patterns, conclusions, and process improvements. Analytics in the healthcare industry uses both present and historical data to generate macro and micro insights that support patient and Company decision-making. Due to the leading players, the Medication Analytic Services segment leads the market. The companies introduce new products and make them easily accessible to customers.

For instance, in July 2021, LGM Pharma announced that it would provide pharmaceutical developers, manufacturers, and compounding pharmacies with contract analytical testing and stability services. The business currently provides analytical services as a component of its integrated contract development and manufacturing (CDMO) operations, but it is now making its facilities and staff available as a stand-alone contract service.

Additionally in June 2022, With the help of data analytics and artificial intelligence, MetroMedi, the fastest-growing online pharmacy and e-health and wellness retailer in South India (Hyderabad), has introduced health advisory services for their customers' health and wellbeing. Data analytics can benefit every facet of patient care and operational management in the healthcare industry. It aids in boosting disease prevention, enhancing clinical care delivery, and assessing the efficacy of various treatment methods.

And in January 2023, Amazon is increasing its healthcare business by launching a prescription drug discount program. The retail behemoth announced Tuesday that it would introduce RxPass, a subscription service for Prime subscribers. According to Amazon, customers will pay USD 5 per month to fill as many prescriptions as they require from a list of approximately 50 generic pharmaceuticals, which are typically less expensive equivalents of name-brand drugs.

Geographical Analysis

North America holds the largest market share in the global Medication management market.

North America dominates the global Medication management market primarily due to factors like the presence of major companies, the high prevalence of chronic diseases in the area, and the well-established healthcare infrastructure are only a few of the major factors responsible for the market's growth. North America dominates the global medication management market due to the widespread use of IT in healthcare, technological improvements, and the prevalence of infectious and chronic diseases. The increase in prescriptions is one of the main factors contributing to the region's dominance.

Contributing variables include multiple small- and medium-sized businesses that offer medication management systems to different hospitals and pharmacies, a high familiarity with new technology, and a need for primary care physicians.

For instance, in March 2022, Hamilton Beach Brands, Inc. and HealthBeacon plc introduced the Smart Sharps Bin Injection Care Management System in the US. The Smart Sharps Bin tracks injection compliance, provides smart medication management reminders, and provides live customer assistance around-the-clock and safe and convenient syringe disposal through the United States Postal Service's approved mail-back Program. Such product launches in the area are likely to support the growth of the medication management system in North America throughout the anticipated time frame.

Competitive Landscape

The Medication management market is moderately competitive with local and global companies' presence. GE Healthcare, QUALCOMM Incorporated, Omnicell, Inc, Talyst, LLC, Allscripts Healthcare Solutions Inc., ARxIUM, Becton Dickinson and Company, Cerner Corporation, QuadraMed Affinity Corporation, McKesson Corporation and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in August 2022, CareDx Inc.,announced the launch of AlloHome, a pan-organ patient monitoring tool that can gather health data while a patient is at home and is accessible on the AlloCare app, has recently been introduced. Patients who use AlloHome get Bluetooth gadgets, such a blood pressure cuff and a glucose meter, that immediately pair with a smart hub in the house. Data is also sent to the patient's AlloCare app.

Omnicell, Inc.

Overview: Omnicell, Inc., a major provider of healthcare technology, has its corporate headquarters in Mountain View, California. In addition to automated solutions for handling prescriptions in hospitals and other healthcare facilities, it also develops software for patient engagement and medication adherence packaging. Under the brand names Omnicell and EnlivenHealth, it sells its products.

Product Portfolio:

Omnicell's Point of Care: Eliminate nurse countbacks with the Controlled Substance Dispenser for greater efficiency and inventory accuracy. Remotely preselect medications directly from the EHR for fast retrieval at Omnicell ADC.

The global Medication management market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Product launches by industry participants are aiding the market to develop.
      • 4.1.1.2. The growing number of hospitals putting more money into innovative technology.
    • 4.1.2. Restraints:
      • 4.1.2.1. Lack of awareness is expected to hamper the market's growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis
  • 5.4 Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Software Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Software Type
    • 7.1.2. Market Attractiveness Index, By Software Type
  • 7.2. Computerized Physician Order Entry (CPOE)
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
    • 7.2.3. Clinical Decision Support System (CDSS)
    • 7.2.4. Electronic Medication Administration Records
    • 7.2.5. Inventory Management System
    • 7.2.6. Others

8. By Service

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
    • 8.1.2. Market Attractiveness Index, By Service
  • 8.2. Medication Analytic Services
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 8.3. ADE Surveillance Services
  • 8.4. Point of Care Verification Services

9. By Mode of Delivery

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 9.1.2. Market Attractiveness Index, By Mode of Delivery
  • 9.2. Web-based
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 9.3. Cloud-based
  • 9.4. On-premise

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 10.3. Pharmacies
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Software Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Software Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Software Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Software Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Software Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Products Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. GE Healthcare
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. QUALCOMM Incorporated
  • 13.3. Omnicell, Inc
  • 13.4. Talyst, LLC
  • 13.5. Allscripts Healthcare Solutions Inc.
  • 13.6. ARxIUM
  • 13.7. Becton Dickinson and Company
  • 13.8. Cerner Corporation
  • 13.9. QuadraMed Affinity Corporation
  • 13.10. McKesson Corporation

LIST NOT EXHAUSTIVE

14. Global Medication management Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Application
  • 14.3. Contact Us